RESUMO
Medical devices have been targets of hacking for over a decade, and this cybersecurity issue has affected many types of medical devices. Lately, the potential for hacking of cardiac devices (pacemakers and defibrillators) claimed the attention of the media, patients, and health care providers. This is a burgeoning problem that our newly electronically connected world faces. In this paper from the Electrophysiology Section Council, we briefly discuss various aspects of this relatively new threat in light of recent incidents involving the potential for hacking of cardiac devices. We explore the possible risks for the patients and the effect of device reconfiguration in an attempt to thwart cybersecurity threats. We provide an outline of what can be done to improve cybersecurity from the standpoint of the manufacturer, government, professional societies, physician, and patient.
Assuntos
Segurança Computacional , Desfibriladores Implantáveis , Técnicas Eletrofisiológicas Cardíacas/instrumentação , Marca-Passo Artificial , HumanosAssuntos
Eletrofisiologia Cardíaca/educação , Cardiopatias , Ablação por Cateter/métodos , Ablação por Cateter/normas , Competência Clínica , Educação , Cardioversão Elétrica/métodos , Cardioversão Elétrica/normas , Técnicas Eletrofisiológicas Cardíacas/métodos , Técnicas Eletrofisiológicas Cardíacas/normas , Bolsas de Estudo/métodos , Bolsas de Estudo/normas , Diretrizes para o Planejamento em Saúde , Cardiopatias/diagnóstico , Cardiopatias/terapia , HumanosAssuntos
Cardiologia/educação , Ablação por Cateter , Educação de Pós-Graduação em Medicina , Cardioversão Elétrica , Técnicas Eletrofisiológicas Cardíacas , Cardiologia/normas , Ablação por Cateter/normas , Competência Clínica , Credenciamento , Currículo , Educação de Pós-Graduação em Medicina/normas , Cardioversão Elétrica/normas , Técnicas Eletrofisiológicas Cardíacas/normas , HumanosAssuntos
Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/terapia , Cardiologia , Consenso , Técnicas Eletrofisiológicas Cardíacas/normas , Garantia da Qualidade dos Cuidados de Saúde , Sociedades Médicas , Técnicas Eletrofisiológicas Cardíacas/instrumentação , Humanos , Pessoa de Meia-Idade , Melhoria de QualidadeRESUMO
INTRODUCTION: Ventricular tachycardia (VT) arising from the right ventricular inflow (RVI) region is uncommon. There is minimal literature on the clinical and electrocardiographic characteristics of RVI VT. METHODS: A retrospective analysis of patients with RVI VT who underwent electrophysiology study between 2006 and 2011 was performed. Patients with structural heart disease (including arrhythmogenic right ventricular dysplasia) were excluded. RESULTS: Seventy patients underwent an electrophysiology study for VT arising from the right ventricle during the study period. Nine patients (13%) met the inclusion criteria for RVI VT and were the subject of this analysis. The median age was 46 years (range, 14-71), and VT cycle length was 295 milliseconds (range, 279-400 milliseconds). All VTs had an left bundle-branch block morphology. An inferiorly directed QRS axis was noted in 7 (78%) of 9 patients and a left superior axis in 2 (22%) of 9 patients. A QS or rS pattern was noted in all patients in aVR and V(1). A transition from S to R wave occurred in V(3) to V(5) in all patients, with 78% of the patients transitioning in V(4) or V(5). Ablation was attempted in 8 (89%) of 9 patients and was successful in 6 (67%) of 9 patients. Ablation was limited in all unsuccessful patients due to the proximity to the His and risk of complete heart block. CONCLUSIONS: Electrocardiographic findings of a left bundle-branch block with a normal QRS axis, QS or rS patterns in aVR and V(1), and late S to R transition (V(4)/V(5)) are commonly found in RVI VT. Because of the proximity to the His, ablation of RVI VT may be more challenging than that of right ventricular outflow tract VT.
Assuntos
Taquicardia Ventricular/fisiopatologia , Função Ventricular Direita , Adolescente , Adulto , Idoso , Bloqueio de Ramo/complicações , Bloqueio de Ramo/diagnóstico , Ablação por Cateter , Eletrocardiografia , Técnicas Eletrofisiológicas Cardíacas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Taquicardia Ventricular/complicações , Taquicardia Ventricular/cirurgia , Adulto JovemAssuntos
Eletrofisiologia Cardíaca/educação , Currículo/normas , Bolsas de Estudo/normas , Arritmias Cardíacas/diagnóstico , Eletrofisiologia Cardíaca/normas , Estimulação Cardíaca Artificial , Morte Súbita Cardíaca , Eletrocardiografia , Técnicas Eletrofisiológicas Cardíacas , Coração/fisiologia , HumanosRESUMO
Patients with coronary artery disease, depressed left ventricular ejection fraction, and nonsustained ventricular tachycardia (VT) have a high mortality rate due to arrhythmic (arrhythmic death/cardiac arrest) and other cardiac causes. The Multicenter UnSustained Tachycardia Trial (MUSTT) investigated whether electrophysiologic study (EPS) was helpful in choosing drug or defibrillator therapy in patients induced into sustained VT. The events committee attempted to categorize follow-up events in patients in MUSTT and to present a detailed breakdown of events. A derivative of the Hinkle-Thaler classification was used, incorporating lessons from other multicenter studies. The committee was blinded to results of EPS and implantable cardioverter-defibrillator (ICD) or other antiarrhythmic therapy status of patients. The primary end point was cardiac arrest or death from arrhythmia. Secondary end points were death from all causes, cardiac causes, and spontaneous sustained VT. Classifications were death and cardiac arrest. Each was similarly divided as arrhythmic with 14 subcategories, e.g., unwitnessed or related to EPS and nonarrhythmic with 10 subcategories, e.g., ischemia. Terminal VF in progressive heart failure was considered nonarrhythmic. Events were reviewed by 2 members. Disagreements were resolved by the 2 members or, if needed, by the full committee. Of the 2,202 patients in MUSTT, there were 902 deaths. Sustained VT requiring cardioversion occurred in 182 patients. An additional 94 patients had resuscitated cardiac arrests. Events occurred in 1,027 patients, and all were reviewed. The 3 leading events were deaths that were classed as sudden/unwitnessed (23% of 902), due to progressive heart failure (22%), or due to noncardiovascular causes (18%). Arrhythmic deaths or cardiac arrests were highest in inducible patients randomized to no antiarrhythmic therapy; next were inducible patients receiving an ICD; and lowest were in patients who were noninducible. In conclusion, the classification system provided a detailed breakdown of events in consistent categories, showing utility for event analysis and interpretation and development of therapeutic strategies. The classifications assigned by the committee were used in all MUSTT outcomes reports, thus affecting all reported outcomes and overall interpretations of the MUSTT.
Assuntos
Doença da Artéria Coronariana/mortalidade , Taquicardia Ventricular/mortalidade , Antiarrítmicos/uso terapêutico , Doença da Artéria Coronariana/complicações , Morte Súbita Cardíaca/epidemiologia , Desfibriladores Implantáveis , Cardioversão Elétrica , Técnicas Eletrofisiológicas Cardíacas , Feminino , Humanos , Masculino , Estudos Prospectivos , Método Simples-Cego , Volume Sistólico , Taquicardia Ventricular/etiologia , Taquicardia Ventricular/terapiaAssuntos
Coleta de Dados/estatística & dados numéricos , Técnicas de Diagnóstico Cardiovascular/estatística & dados numéricos , Técnicas de Diagnóstico Cardiovascular/normas , Técnicas Eletrofisiológicas Cardíacas/normas , Eletrofisiologia/normas , American Heart Association , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/fisiopatologia , Doenças Cardiovasculares/terapia , Coleta de Dados/normas , Técnicas Eletrofisiológicas Cardíacas/métodos , Eletrofisiologia/métodos , Humanos , Terminologia como Assunto , Estados UnidosAssuntos
Coleta de Dados/estatística & dados numéricos , Técnicas de Diagnóstico Cardiovascular/estatística & dados numéricos , Técnicas de Diagnóstico Cardiovascular/normas , Técnicas Eletrofisiológicas Cardíacas/normas , Eletrofisiologia/normas , American Heart Association , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/fisiopatologia , Doenças Cardiovasculares/terapia , Coleta de Dados/normas , Técnicas Eletrofisiológicas Cardíacas/métodos , Eletrofisiologia/métodos , Humanos , Terminologia como Assunto , Estados UnidosRESUMO
INTRODUCTION: Retroconduction (ventriculo-atrial conduction) remains a problem for patients with implanted cardiac rhythm devices. Pacemaker algorithms can detect and terminate endless loop tachycardia (ELT), but actual prevention of ELT may require anti-arrhythmic drugs (AADs). Similarly, AADs can affect ICD rhythm discrimination algorithms that depend on atrio-ventricular ratios. There is concern whether these drugs remain effective during stress situations. METHODS: Electrophysiologic studies that included retroconduction testing using slow ramp pacing were done in 1332 patients. The presence or absence of retroconduction at baseline and with drug was recorded, as was the rate at block. As a stress surrogate, isoproterenol was used to test retroconduction and reversal of drug-induced block. RESULTS: Procainamide, mexiletine, phenytoin, disopyramide, quinidine, beta-blockers, encainide, and amiodarone caused complete retrograde block or decreased the rate at which block occurred (mean 76% of patients, p < 0.008), whereas digoxin, lidocaine, diltiazem, and verapamil did not. Isoproterenol (in the absence of AADs) increased the rate at block in 82% of 404 patients with retroconduction at baseline (p < 0.005). Of 319 patients without retroconduction at baseline, 134 (42%) developed retroconduction after isoproterenol. Isoproterenol reversed retrograde block in 39% of patients with block on an AAD. Amiodarone, digoxin, and the combination of digoxin plus a beta-blocker were most effective at resisting this reversal of ventriculo-atrial block (80%, 68%, and 75% respectively). CONCLUSION: Most of the AADs reviewed increase the cycle length at block or abolish retroconduction, while isoproterenol has the opposite effect. Anti-arrhythmic medications, particularly amiodarone, digoxin, and the combination of digoxin plus a beta-blocker may be considered for a patient with multiple ELT episodes or certain ICD detection problems.
Assuntos
Nó Atrioventricular/efeitos dos fármacos , Fármacos Cardiovasculares/farmacologia , Desfibriladores Implantáveis , Bloqueio Cardíaco/induzido quimicamente , Bloqueio Cardíaco/terapia , Marca-Passo Artificial , Agonistas Adrenérgicos beta/farmacologia , Agonistas Adrenérgicos beta/uso terapêutico , Antiarrítmicos/farmacologia , Antiarrítmicos/uso terapêutico , Nó Atrioventricular/fisiopatologia , Estimulação Cardíaca Artificial , Fármacos Cardiovasculares/efeitos adversos , Fármacos Cardiovasculares/uso terapêutico , Terapia Combinada , Resistência a Medicamentos/efeitos dos fármacos , Quimioterapia Combinada , Técnicas Eletrofisiológicas Cardíacas , Feminino , Bloqueio Cardíaco/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Humanos , Isoproterenol/farmacologia , Isoproterenol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Projetos de Pesquisa , Taquicardia/fisiopatologia , Taquicardia/terapia , Resultado do TratamentoRESUMO
BACKGROUND AND STUDY OBJECTIVE: Conventional programmed electrical stimulation (PES) is useful for establishing inducibility or noninducibility of clinical ventricular arrhythmias (VA), but is complex and time-consuming. This study compared a standard PES protocol with ultrarapid train stimulation (UTS) in a broad range of patients with and without a history of ventricular arrhythmias or structural heart disease. METHODS: Patients prospectively underwent electrophysiologic testing with both UTS and conventional PES protocols in a randomized, crossover design. RESULTS: The results were concordant in 79% of 150 matched pairs of comparisons in 104 patients (NS). There were no differences related to underlying heart disease or arrhythmia, or antiarrhythmic treatment. Induction of nonclinical arrhythmias with the two methods was similar (P = 0.524). Inhibition phenomena were minor except in some patients receiving amiodarone. Fewer drive-extrastimuli sequences and less time were needed to complete the trains protocol (P < 0.0001). CONCLUSIONS: In cases where the main intent is to induce ventricular arrhythmias, UTS yields results that are similar to those of conventional PES protocols in a shorter length of time.
Assuntos
Estimulação Cardíaca Artificial/métodos , Técnicas Eletrofisiológicas Cardíacas , Antiarrítmicos/uso terapêutico , Estudos Cross-Over , Eletrocardiografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Período Refratário Eletrofisiológico , Reprodutibilidade dos Testes , Taquicardia Ventricular/fisiopatologia , Fibrilação Ventricular/fisiopatologiaRESUMO
BACKGROUND: Fifty percent of deaths in patients with coronary disease occur suddenly. Although many factors correlate with increased mortality, there is little information regarding the influence of these factors on mode of death. As such, optimum methods to determine patients most likely to benefit from implantable defibrillator therapy are unclear. METHODS AND RESULTS: We analyzed the relation of ejection fraction and inducible ventricular tachyarrhythmias to mode of death in all 1791 patients enrolled in the Multicenter Unsustained Tachycardia Trial who did not receive antiarrhythmic therapy. Total mortality and arrhythmic deaths/cardiac arrests occurred more frequently in patients with ejection fraction <30% than in those with ejection fraction of 30% to 40%. The percentage of deaths classified as arrhythmic was similar in patients with ejection fraction <30% or > or =30%. The relative contribution of arrhythmic events to total mortality was significantly higher in patients with inducible tachyarrhythmia (58% of deaths in inducible patients versus 46% in noninducible patients, P=0.004). The higher percentage of events that were arrhythmic among patients with inducible tachyarrhythmia appeared more distinct among patients with an ejection fraction > or =30% (61% of events were arrhythmic among inducible patients with ejection fraction > or =30% and only 42% among noninducible patients, P=0.002). CONCLUSIONS: Both low ejection fraction and inducible tachyarrhythmias identify patients with coronary disease at increased mortality risk. Ejection fraction does not discriminate between modes of death, whereas inducible tachyarrhythmia identifies patients for whom death, if it occurs, is significantly more likely to be arrhythmic, especially if ejection fraction is > or =30%.
Assuntos
Doença da Artéria Coronariana/mortalidade , Morte Súbita Cardíaca/etiologia , Volume Sistólico , Taquicardia Ventricular/mortalidade , Canadá/epidemiologia , Estimulação Cardíaca Artificial , Doença Crônica , Comorbidade , Doença da Artéria Coronariana/fisiopatologia , Doença da Artéria Coronariana/terapia , Morte Súbita Cardíaca/epidemiologia , Desfibriladores Implantáveis , Técnicas Eletrofisiológicas Cardíacas , Humanos , Estudos Multicêntricos como Assunto/estatística & dados numéricos , Modelos de Riscos Proporcionais , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Medição de Risco , Fatores de Risco , Taxa de Sobrevida , Taquicardia Ventricular/fisiopatologia , Taquicardia Ventricular/terapia , Estados Unidos/epidemiologiaRESUMO
INTRODUCTION: Nonsustained ventricular tachycardia (NSVT) occurs frequently in the postoperative period (< or = 30 days) after coronary artery bypass graft (CABG) surgery, a setting where many factors may play a role in its genesis. The prognosis of NSVT in this setting in patients with left ventricular (LV) dysfunction is unknown. This study was designed to assess its significance. METHODS AND RESULTS: We compared the outcome of untreated patients enrolled in the Multicenter Unsustained Tachycardia Trial with coronary artery disease (CAD), LV dysfunction, and NSVT identified postoperatively after CABG (n = 228; mean age 67 years, 84% males) versus nonpostoperative settings (n = 1,302; mean age 66 years, 85% males). Sustained monomorphic ventricular tachycardia was induced in 27% and 33% (P = 0.046) of patients with postoperative and nonpostoperative NSVT, respectively. The 2- and 5-year rates of arrhythmic events were 6% and 16%, respectively, in postoperative patients versus 15% and 29% in nonpostoperative patients (unadjusted P = 0.0020, adjusted P = 0.0082). The 2- and 5-year overall mortality rates were 15% and 36%, respectively, for postoperative patients versus 24% and 47% for nonpostoperative patients (unadjusted P = 0.0005, adjusted P = 0.027). Patients whose NSVT was identified early (<10 days) versus late (10-30 days) after CABG had significantly lower 2- (13% vs 23%) and 5-year (30% vs 52%) mortality rates (unadjusted P = 0.024, adjusted P = 0.018). CONCLUSION: In this population of patients with CAD and LV dysfunction, the occurrence of postoperative NSVT, especially within 10 days after CABG, portends a far better outcome than when it occurs in nonpostoperative settings. This suggests that in a such setting, NSVT represents a less specific risk factor for future events and should be considered when assigning risk and treatment of similar patients.